Home › Companies › ALLOGENE THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and ALLOGENE THERAPEUTICS INC.’s Form 8-K, filed 2024-06-10 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore ALLOGENE THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are ALLOGENE THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-10 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: John DeYoung | 121,177,479 | -- | -- | 17,019,993 | 15,800,932 | Majority: yes |
| Elect Director: Franz Humer, Ph.D. | 119,919,567 | -- | -- | 18,277,905 | 15,800,932 | Majority: yes |
| Elect Director: Joshua Kazam | 127,917,055 | -- | -- | 10,280,417 | 15,800,932 | Majority: yes |
| Elect Director: Stephen Mayo, Ph.D. | 130,166,905 | -- | -- | 8,030,567 | 15,800,932 | Majority: yes |
| Proposal 2. Approval, on an Advisory Basis, of the Compensation of the Company's Named Executive Officers The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in | 119,741,038 | 16,298,878 | 2,157,556 | -- | 15,800,932 | Majority: yes |
| Proposal 3. Ratification of the Selection of Independent Registered Public Accounting Firm The Company's stockholders ratified the selection by the Audit Committee of the Company's Board of Directors of Ernst & Young LLP as the Company's in | 152,503,468 | 1,359,400 | 135,536 | -- | 0 | Majority: yes |
Source: ALLOGENE THERAPEUTICS INC., Form 8-K, filed with the SEC on 2024-06-10 — read the filing on EDGAR.
Each item below shows how the 175 asset managers that disclosed a ALLOGENE THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 8 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
ALLOGENE THERAPEUTICS INC.’s own tally for this item (“Proposal 2. Approval, on an Advisory Basis, of the Compensation of the Company's Named Executive Officers The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive offic”): 119,741,038 for, 16,298,878 against, per its Form 8-K filed 2024-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 170,452,967 outstanding shares: 70% for, 10% against (80% of the company cast a for/against vote).
The 172 asset managers below cast 79% of the shares they voted on this item FOR (74,900,148 for, 20,201,122 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 36,467,339 | 0 | 0 | 0 | For |
| Vanguard | 11,708,225 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 7,729,862 | 0 | 0 | Against |
| PRIMECAP MANAGEMENT CO/CA/ | 5,567,586 | 0 | 0 | 0 | For |
| BlackRock | 4,009,414 | 62,179 | 0 | 0 | For |
| JPMorgan | 2,958,696 | 1,793 | 0 | 0 | For |
| State Street | 2,682,503 | 35,545 | 0 | 0 | For |
| Woodline Partners LP | 2,642,690 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,926,671 | 0 | 0 | 0 | For |
| Wildcat Capital Management, LLC | 0 | 0 | 1,920,787 | 0 | Abstain |
| Vida Ventures Advisors, LLC | 1,798,163 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 1,718,652 | 0 | 0 | Against |
| Vestal Point Capital, LP | 0 | 986,117 | 0 | 0 | Against |
| Dimensional | 0 | 939,501 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 829,338 | 0 | 0 | Against |
| Rafferty Asset Management, LLC | 0 | 829,338 | 0 | 0 | Against |
| Two Sigma | 0 | 804,245 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 801,297 | 0 | 0 | 0 | For |
| BBR PARTNERS, LLC | 798,899 | 0 | 0 | 0 | For |
| Citadel | 789,961 | 0 | 0 | 0 | For |
| NORDEA INVESTMENT MANAGEMENT AB | 0 | 742,114 | 0 | 0 | Against |
| Northern Trust | 538,731 | 47 | 0 | 0 | For |
| Goldman Sachs | 0 | 463,932 | 0 | 0 | Against |
| Cerity Partners LLC | 430,481 | 0 | 0 | 0 | For |
| Coastal Bridge Advisors, LLC | 0 | 386,045 | 0 | 0 | Against |
Showing the 25 largest of 172 asset managers. See all 172 in the interactive database.
Combines 3 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
ALLOGENE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Franz Humer, Ph.D.”): 119,919,567 for, 18,277,905 withheld, per its Form 8-K filed 2024-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 170,452,967 outstanding shares: 70% for, 11% withheld (81% of the company cast a for/withheld vote).
The 63 asset managers below cast 100% of the shares they voted on this item FOR (31,417,352 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 15,784,639 | 0 | 681,640 | 0 | For |
| Vanguard | 11,538,299 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 3,466,056 | 0 | Abstain |
| PRIMECAP Odyssey Funds | 1,926,671 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 859,326 | 0 | Abstain |
| Direxion Shares ETF Trust | 0 | 0 | 829,338 | 0 | Abstain |
| State Street | 783 | 0 | 772,299 | 0 | Abstain |
| Dimensional | 0 | 0 | 598,915 | 0 | Abstain |
| JPMorgan | 591,783 | 0 | 0 | 0 | For |
| BlackRock | 515,139 | 0 | 0 | 0 | For |
| Equitable | 146,911 | 0 | 191,781 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 330,399 | 0 | Abstain |
| TIAA | 0 | 0 | 273,456 | 0 | Abstain |
| Goldman Sachs | 0 | 0 | 243,287 | 0 | Abstain |
| Global X | 194,981 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 170,481 | 0 | 0 | 0 | For |
| SEI | 159,080 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 149,496 | 0 | Abstain |
| Amplify ETF Trust | 0 | 0 | 147,277 | 0 | Abstain |
| Delaware/Macquarie | 0 | 0 | 146,779 | 0 | Abstain |
| ProShares | 0 | 0 | 140,284 | 0 | Abstain |
| American Century | 0 | 0 | 128,919 | 0 | Abstain |
| Lincoln Financial | 32,239 | 0 | 85,015 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 106,980 | 0 | Abstain |
| RMB INVESTORS TRUST | 0 | 0 | 101,375 | 0 | Abstain |
Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.
Combines 4 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
ALLOGENE THERAPEUTICS INC.’s own tally for this item (“Elect Director: John DeYoung”): 121,177,479 for, 17,019,993 withheld, per its Form 8-K filed 2024-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 170,452,967 outstanding shares: 71% for, 10% withheld (81% of the company cast a for/withheld vote).
The 63 asset managers below cast 100% of the shares they voted on this item FOR (31,480,142 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 15,784,639 | 0 | 681,640 | 0 | For |
| Vanguard | 11,538,299 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 3,466,056 | 0 | Abstain |
| PRIMECAP Odyssey Funds | 1,926,671 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 859,326 | 0 | Abstain |
| Direxion Shares ETF Trust | 0 | 0 | 829,338 | 0 | Abstain |
| State Street | 783 | 0 | 772,299 | 0 | Abstain |
| Dimensional | 0 | 0 | 598,915 | 0 | Abstain |
| JPMorgan | 591,783 | 0 | 0 | 0 | For |
| BlackRock | 515,139 | 0 | 0 | 0 | For |
| Equitable | 146,911 | 0 | 191,781 | 0 | Abstain |
| AIG/SunAmerica | 0 | 0 | 330,399 | 0 | Abstain |
| TIAA | 0 | 0 | 273,456 | 0 | Abstain |
| Goldman Sachs | 0 | 0 | 243,287 | 0 | Abstain |
| Global X | 194,981 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 170,481 | 0 | 0 | 0 | For |
| SEI | 159,080 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 149,496 | 0 | Abstain |
| Amplify ETF Trust | 0 | 0 | 147,277 | 0 | Abstain |
| Delaware/Macquarie | 0 | 0 | 146,779 | 0 | Abstain |
| ProShares | 0 | 0 | 140,284 | 0 | Abstain |
| American Century | 0 | 0 | 128,919 | 0 | Abstain |
| Lincoln Financial | 32,239 | 0 | 85,015 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 106,980 | 0 | Abstain |
| RMB INVESTORS TRUST | 0 | 0 | 101,375 | 0 | Abstain |
Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.
Combines 3 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
ALLOGENE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Joshua Kazam”): 127,917,055 for, 10,280,417 withheld, per its Form 8-K filed 2024-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 170,452,967 outstanding shares: 75% for, 6% withheld (81% of the company cast a for/withheld vote).
The 63 asset managers below cast 100% of the shares they voted on this item FOR (37,097,645 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 16,466,279 | 0 | 0 | 0 | For |
| Vanguard | 11,538,299 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,466,056 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,926,671 | 0 | 0 | 0 | For |
| Charles Schwab | 859,326 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 829,338 | 0 | Abstain |
| State Street | 783 | 0 | 772,299 | 0 | Abstain |
| Dimensional | 0 | 0 | 598,915 | 0 | Abstain |
| JPMorgan | 591,783 | 0 | 0 | 0 | For |
| BlackRock | 515,139 | 0 | 0 | 0 | For |
| Equitable | 185,184 | 0 | 153,508 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 330,399 | 0 | Abstain |
| TIAA | 273,456 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 0 | 243,287 | 0 | Abstain |
| Global X | 194,981 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 170,481 | 0 | 0 | 0 | For |
| SEI | 159,080 | 0 | 0 | 0 | For |
| John Hancock | 108,692 | 0 | 40,804 | 0 | For |
| Amplify ETF Trust | 147,277 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 146,779 | 0 | Abstain |
| ProShares | 0 | 0 | 140,284 | 0 | Abstain |
| American Century | 0 | 0 | 128,919 | 0 | Abstain |
| Lincoln Financial | 32,239 | 0 | 85,015 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 106,980 | 0 | Abstain |
| RMB INVESTORS TRUST | 0 | 0 | 101,375 | 0 | Abstain |
Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
ALLOGENE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Stephen Mayo, Ph.D.”): 130,166,905 for, 8,030,567 withheld, per its Form 8-K filed 2024-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 170,452,967 outstanding shares: 76% for, 5% withheld (81% of the company cast a for/withheld vote).
The 63 asset managers below cast 100% of the shares they voted on this item FOR (38,159,280 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 16,466,279 | 0 | 0 | 0 | For |
| Vanguard | 11,538,299 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,466,056 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,926,671 | 0 | 0 | 0 | For |
| Charles Schwab | 859,326 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 829,338 | 0 | Abstain |
| State Street | 772,033 | 0 | 1,049 | 0 | For |
| Dimensional | 0 | 0 | 598,915 | 0 | Abstain |
| JPMorgan | 591,783 | 0 | 0 | 0 | For |
| BlackRock | 515,139 | 0 | 0 | 0 | For |
| Equitable | 338,692 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 330,399 | 0 | Abstain |
| TIAA | 273,456 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 0 | 243,287 | 0 | Abstain |
| Global X | 194,981 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 170,481 | 0 | 0 | 0 | For |
| SEI | 159,080 | 0 | 0 | 0 | For |
| John Hancock | 108,692 | 0 | 40,804 | 0 | For |
| Amplify ETF Trust | 147,277 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 146,779 | 0 | Abstain |
| ProShares | 0 | 0 | 140,284 | 0 | Abstain |
| American Century | 0 | 0 | 128,919 | 0 | Abstain |
| Lincoln Financial | 100,039 | 0 | 17,215 | 0 | For |
| ALPS ETF Trust | 0 | 0 | 106,980 | 0 | Abstain |
| RMB INVESTORS TRUST | 0 | 0 | 101,375 | 0 | Abstain |
Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
ALLOGENE THERAPEUTICS INC.’s own tally for this item (“Proposal 3. Ratification of the Selection of Independent Registered Public Accounting Firm The Company's stockholders ratified the selection by the Audit Committee of the Company's Board of Directors of Ernst & Young LLP”): 152,503,468 for, 1,359,400 against, per its Form 8-K filed 2024-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 170,452,967 outstanding shares: 89% for, 0.8% against (90% of the company cast a for/against vote).
The 63 asset managers below cast 100% of the shares they voted on this item FOR (41,147,298 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 16,466,279 | 0 | 0 | 0 | For |
| Vanguard | 11,538,299 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,466,056 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,926,671 | 0 | 0 | 0 | For |
| Charles Schwab | 859,326 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 829,338 | 0 | 0 | 0 | For |
| State Street | 773,082 | 0 | 0 | 0 | For |
| Dimensional | 598,915 | 0 | 0 | 0 | For |
| JPMorgan | 591,783 | 0 | 0 | 0 | For |
| BlackRock | 515,139 | 0 | 0 | 0 | For |
| Equitable | 338,692 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 330,399 | 0 | 0 | 0 | For |
| TIAA | 273,456 | 0 | 0 | 0 | For |
| Goldman Sachs | 243,287 | 0 | 0 | 0 | For |
| Global X | 194,981 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 170,481 | 0 | 0 | 0 | For |
| SEI | 159,080 | 0 | 0 | 0 | For |
| John Hancock | 149,496 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 147,277 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 146,779 | 0 | 0 | 0 | For |
| ProShares | 140,284 | 0 | 0 | 0 | For |
| American Century | 128,919 | 0 | 0 | 0 | For |
| Lincoln Financial | 117,254 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 106,980 | 0 | 0 | 0 | For |
| RMB INVESTORS TRUST | 101,375 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.
Ranked by the number of ALLOGENE THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 170,452,967 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 21.39% |
| 2 | Vanguard | 6.87% |
| 3 | T. Rowe Price | 4.53% |
| 4 | PRIMECAP MANAGEMENT CO/CA/ | 3.27% |
| 5 | BlackRock | 2.39% |
| 6 | JPMorgan | 1.74% |
| 7 | State Street | 1.59% |
| 8 | Woodline Partners LP | 1.55% |
| 9 | PRIMECAP Odyssey Funds | 1.13% |
| 10 | Wildcat Capital Management, LLC | 1.13% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Fidelity Management Research LLC | 14.81% | DEF14A |
| Pfizer Inc. | 12.93% | DEF14A |
| David Bonderman | 10.98% | DEF14A |
| TPG GP A, LLC | 10.98% | DEF14A |
| BlackRock | 10.28% | 13F |
| David Chang, M.D., Ph.D. | 5.89% | DEF14A |
| Arie Belldegrun, M.D. | 5.86% | DEF14A |
| State Street | 5.39% | 13F |
| Vanguard Group | 5.29% | 13F |
| T. Rowe Price | 2.45% | 13F |
Percentages above are of 170,452,967 shares outstanding, as reported by ALLOGENE THERAPEUTICS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ALLOGENE THERAPEUTICS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At ALLOGENE THERAPEUTICS INC.'s shareholder meeting held 2024-06-05, in the 2023-2024 proxy season, 175 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 1,420 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers… — FOR was 88% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ALLOGENE THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-10.
ALLOGENE THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.